GENTEX CORP (GNTX)       27.09  -0.37 (-1.35%)

27.09  -0.37 (-1.35%)

US3719011096 - Common Stock


Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GNTX. GNTX was compared to 42 industry peers in the Auto Components industry. GNTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, GNTX is valued expensive at the moment.




Profitability

Profitability Rating

7

GNTX has a Return On Assets of 17.49%. This is amongst the best returns in the industry. The industry average is 3.60%. GNTX outperforms 97% of its industry peers.
GNTX's Return On Equity of 19.88% is amongst the best of the industry. GNTX does better than the industry average Return On Equity of 12.07%.

GNTX has a Profit Margin of 17.48%. This is amongst the best returns in the industry. The industry average is 4.04%. GNTX outperforms 97% of its industry peers.
GNTX has a Piotroski-F score of 4.00. This indicates an average health and profitability for GNTX.
VS Industry

ROA (17.49%) VS Industry: 97% outperformed.

-201.92
20.84

ROE (19.88%) VS Industry: 80% outperformed.

0.84
36.87

Profit Margin (17.48%) VS Industry: 97% outperformed.

-13,702.44
392.40

Valuation

Valuation Rating

1

With a Price/Earnings Ratio of 20.22, GNTX is valued on the expensive side.
The Forward Price/Earnings Ratio of 13.50 indicates a correct valuation of GNTX.
When comparing the current price to the book value of GNTX, we can conclude it is valued correctly. It is trading at 3.12 times its book value.
GNTX's Price/Earning Ratio is slightly more expensive than the industry average, which is at 13.31.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates GNTX does not grow enough to justify the current Price/Earnings ratio.
Compared to an average industry price book ratio of 1.44, GNTX is valued more expensive than its industry peers. 85% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 7.15, GNTX is valued more expensive than its industry peers.
VS Industry

Price/Earnings (20.22) VS Industry: 24% outperformed.

346.45
3.71

Price/Book (3.12) VS Industry: 15% outperformed.

61.26
0.47

Enterprise Value/ EBITDA (11.38) VS Industry: 27% outperformed.

53.73
0.21

Growth

Growth Rating

5

The Earnings Per Share is expected to grow by 21.49% on average over the next 5 years. This is a very strong growth
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
Measured over the past 5 years, GNTX shows a small growth in Earnings Per Share. The EPS has been growing by 4.25% on average per year.

GNTX shows a decrease in Revenue. In the last year, the revenue decreased by -0.50%.
The Revenue has been growing slightly by 0.62% on average over the past 5 years.
Based on estimates for the next 5 years, GNTX will show a small growth in Revenue. The Revenue will grow by 8.71% on average per year.
The earnings per share for GNTX have decreased strongly by -22.09% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS4.25% -2.95% -22.09% 0.79% 16.04% 18.12% 21.49%
Revenue0.62% -1.91% -0.5% 11.7% 13.14% 12.14% 8.71%

Health

Health Rating

8

GNTX has a Current Ratio of 3.73. This indicates that GNTX is financially healthy and has no problem in meeting its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 1.72, GNTX is better placed than the average industry peer to meet its short term obligations.
A Quick Ratio of 2.15 indicates that GNTX has no problem at all paying its short term obligations.
When comparing the Quick Ratio to an average industry Quick Ratio of 1.03, GNTX is better placed than the average industry peer to meet its short term obligations.

With a Debt to Equity ratio of 0.00, GNTX is one of the better performing companies in its industry. It outperforms 92% of its industry peers.
GNTX has an Altman-Z score of 17.17. This indicates that GNTX is financially healthy and little risk of bankruptcy at the moment.
GNTX has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.71. GNTX has a better score than 97% of its industry peers.
The Piotroski-F score of GNTX is 4.00. This is a neutral score and indicates average health and profitability for GNTX.
VS Industry

Debt/Equity (0) VS Industry: 92% outperformed.

14.23
0.00

Quick Ratio (2.15) VS Industry: 80% outperformed.

0.33
25.68

Current Ratio (3.73) VS Industry: 80% outperformed.

0.71
25.68

Altman-Z (17.17) VS Industry: 97% outperformed.

-6.07
19.67

Dividend

Dividend Rating

5

The dividend of GNTX is growing, but earnings are growing more, so the dividend growth is sustainable.
GNTX pays out 28.03% of its income as dividend. This is a sustainable payout ratio.
GNTX has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 1.67%, GNTX has a reasonable but not impressive dividend return.

The dividend of GNTX has a limited annual growth rate of 3.73%.
With a Dividend Yield of 1.67, GNTX pays less dividend than the industry average, which is at 2.77. 84% of the companies listed in the same industry pay a better dividend than GNTX!
GNTX's Dividend Yield is slightly below the S&P500 average, which is at 2.43.
VS Industry

Dividend Yield (1.67%) VS Industry: 16% outperformed.

1.19
5.43
GNTX Daily chart

GENTEX CORP27.09

NASDAQ:GNTX (12/7/2022, 2:21:35 PM)-0.37 (-1.35%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Automobiles & Components
GICS Industry Auto Components
Earnings (Last) 10-28 2022-10-28/bmo Earnings (Next) 01-26 2023-01-26
Ins Owners 0.17% Inst Owners 81.56%
Market Cap 6.35B Analysts 78.75
Valuation
PE 20.22 Fwd PE 13.5
PEG (NY) 25.64 PEG (5Y) 4.76
P/S 2.75 P/B 3.12
EV/EBITDA 11.38
Dividend
Dividend Yield 1.67% Dividend Growth 3.73%
DP 28.03% Ex-Date 10-06 2022-10-06 (0.12)
Growth
EPS 1Y -22.09% EPS 3Y -2.95%
EPS 5Y 4.25% EPS growth Q2Q -3.13%
EPS Next Y 0.79% EPS Next 2Y 16.04%
EPS Next 3Y 18.12% EPS Next 5Y 21.49%
Revenue growth 1Y -0.5% Revenue growth 3Y -1.91%
Revenue growth 5Y 0.62% Revenue growth Q2Q 23.53%
Revenue Next Year 11.7% Revenue Next 2Y 13.14%
Revenue Next 3Y 12.14% Revenue Next 5Y 8.71%
Health
Current Ratio 3.73 Quick Ratio 2.15
Altman-Z 17.17 F-Score 4
Debt/Equity 0 WACC 10.23%
ROIC/WACC 3.24
Profitability
ROA 17.49% ROE 19.88%
ROICexgc 33.13% ROIC 19.53%
PM 17.48% OM 20.19%
Asset Turnover 1

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA